Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Small Cell Lung Carcinoma × Bortezomib × 90 days × Clear all

Sponsor

Conditions

Multiple Myeloma 49 Neoplasms, Plasma Cell 5 Immunoglobulin Light-chain Amyloidosis 5 Recurrence 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Paraproteinemias 3 Waldenstrom Macroglobulinemia 2 Renal Insufficiency 2 Neoplasms 2 Lymphoproliferative Disorders 2 Leukemia, Myeloid, Acute 2 Burkitt Lymphoma 2 Amyloidosis 2 beta-Thalassemia 1 Triple Negative Breast Neoplasms 1 Thalassemia 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasm, Residual 1 Myelodysplastic Syndromes 1 Multi-centric Castleman's Disease 1 Macular dystrophy, corneal type 1 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Lymphadenopathy 1 Immunoproliferative Disorders 1 Hematologic Neoplasms 1 HIV Infections 1 Breast Neoplasms 1 Anemia, Sickle Cell 1

Interventions

Carboplatin 19 durvalumab 18 Etoposide 18 atezolizumab 17 PM 01183 10 Topotecan 8 pembrolizumab 6 Specimen Handling 5 Radiosurgery 5 Nivolumab 5 Drug Therapy 5 Paclitaxel 4 Bevacizumab 4 AMG 757 4 anlotinib 3 amrubicin 3 Temozolomide 3 Radiotherapy 3 Platinum 3 Magnetic Resonance Spectroscopy 3 Ipilimumab 3 Docetaxel 3 Cisplatin 3 tremelimumab 2 toripalimab 2 sacituzumab govitecan 2 olaparib 2 monalizumab 2 enzalutamide 2 cabozantinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡